• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
New Challenges in Drug Allergy: the Resurgence of Excipients.药物过敏的新挑战:辅料的再度出现
Curr Treat Options Allergy. 2022;9(3):273-291. doi: 10.1007/s40521-022-00313-6. Epub 2022 Jul 24.
2
Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions.潜在危险:认识赋形剂作为药物和疫苗过敏反应的潜在原因。
J Allergy Clin Immunol Pract. 2021 Aug;9(8):2968-2982. doi: 10.1016/j.jaip.2021.03.002. Epub 2021 Mar 15.
3
COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.COVID 疫苗接种可在有疫苗或其成分过敏史的患者中进行:来自南澳大利亚一家专科诊所的经验。
Intern Med J. 2022 Nov;52(11):1884-1890. doi: 10.1111/imj.15888. Epub 2022 Jul 30.
4
Steroid Allergy: Clinical Features and the Importance of Excipient Testing in a Diagnostic Algorithm.类固醇过敏:临床特征和在诊断算法中赋形剂测试的重要性。
J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1655-1661. doi: 10.1016/j.jaip.2018.01.007. Epub 2018 Jan 31.
5
AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy.阿斯利康ChAdOx1-S型新冠疫苗可安全用于对乙二胺四乙酸(EDTA)过敏的患者。
Allergy Asthma Clin Immunol. 2022 Mar 10;18(1):22. doi: 10.1186/s13223-022-00665-3.
6
Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis.COVID-19 疫苗过敏反应疫苗和疫苗赋形剂检测的诊断准确性:系统评价和荟萃分析。
Allergy. 2023 Jan;78(1):71-83. doi: 10.1111/all.15571. Epub 2022 Nov 23.
7
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.mRNA COVID-19 疫苗首剂过敏反应:赋形剂皮肤试验作用有限。
J Allergy Clin Immunol Pract. 2021 Sep;9(9):3308-3320.e3. doi: 10.1016/j.jaip.2021.06.010. Epub 2021 Jun 22.
8
Vaccine allergy: evidence to consider for COVID-19 vaccines.疫苗过敏:考虑用于 COVID-19 疫苗的证据。
Curr Opin Allergy Clin Immunol. 2021 Aug 1;21(4):401-409. doi: 10.1097/ACI.0000000000000762.
9
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.关于 COVID-19 疫苗过敏反应风险的更新指南以及建议的评估和管理:一个 GRADE 评估和国际共识方法。
J Allergy Clin Immunol. 2023 Aug;152(2):309-325. doi: 10.1016/j.jaci.2023.05.019. Epub 2023 Jun 7.
10
PEGylated liposomes for diagnosis of polyethylene glycol allergy.聚乙二醇化脂质体用于诊断聚乙二醇过敏。
J Allergy Clin Immunol. 2024 Aug;154(2):503-507.e1. doi: 10.1016/j.jaci.2024.03.030. Epub 2024 May 6.

引用本文的文献

1
Towards standardized skin testing for drug-induced allergic reactions.迈向药物性过敏反应的标准化皮肤试验。
Saudi Pharm J. 2025 Jul 9;33(4):26. doi: 10.1007/s44446-025-00031-5.
2
Excipients in pharmaceuticals: mechanisms of hypersensitivity and the role of global pharmacovigilance.药物中的辅料:超敏反应机制及全球药物警戒的作用
Saudi Pharm J. 2025 Jul 8;33(4):18. doi: 10.1007/s44446-025-00004-8.
3
Role of the basophil activation test in the diagnosis and management of immediate drug reaction to injectable growth hormone preparation: a case report.嗜碱性粒细胞活化试验在注射用生长激素制剂速发型药物反应诊断和管理中的作用:一例报告
Immunol Res. 2025 Jun 4;73(1):89. doi: 10.1007/s12026-025-09644-3.
4
Occupational anaphylaxis: A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI).职业性过敏反应:德国过敏与临床免疫学会(DGAKI)立场文件
Allergol Select. 2024 Nov 28;8:407-424. doi: 10.5414/ALX02543E. eCollection 2024.
5
Inconsistent excipient listings in DailyMed: implications for drug safety.《每日药品信息库》中辅料清单不一致:对药物安全性的影响
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6851-6854. doi: 10.1007/s00210-024-03067-x. Epub 2024 Apr 2.
6
Feasibility of a drug allergy registry-based excipient allergy database and call for universal mandatory drug ingredient disclosure: the case of PEG.基于药物过敏登记处的辅料过敏数据库的可行性及呼吁普遍强制披露药物成分:以聚乙二醇为例
Front Allergy. 2024 Jan 16;4:1331036. doi: 10.3389/falgy.2023.1331036. eCollection 2023.
7
Antimicrobial Preservatives for Protein and Peptide Formulations: An Overview.蛋白质和肽类制剂的抗菌防腐剂:概述
Pharmaceutics. 2023 Feb 7;15(2):563. doi: 10.3390/pharmaceutics15020563.

本文引用的文献

1
Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series.聚乙二醇过敏患者接种新型冠状病毒肺炎疫苗的安全性:病例系列
J Allergy Clin Immunol Pract. 2022 Feb;10(2):620-625.e1. doi: 10.1016/j.jaip.2021.11.021. Epub 2021 Dec 20.
2
Carboxymethylcellulose excipient allergy: a case report.羧甲基纤维素赋形剂过敏:一例报告。
J Med Case Rep. 2021 Nov 24;15(1):565. doi: 10.1186/s13256-021-03180-y.
3
Evaluation of Adverse Reactions to Vaccines.疫苗不良反应评估。
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3584-3597. doi: 10.1016/j.jaip.2021.08.002.
4
Hypersensitivity reactions to chemotherapy: an EAACI Position Paper.化疗药物过敏反应:欧洲过敏与临床免疫学会立场文件
Allergy. 2022 Feb;77(2):388-403. doi: 10.1111/all.15113. Epub 2021 Oct 26.
5
Polyethylene Glycol Allergy and Immediate-Type Hypersensitivity Reaction to COVID-19 Vaccination: Case Report.聚乙二醇过敏与新冠疫苗接种后的速发型超敏反应:病例报告
J Investig Allergol Clin Immunol. 2022 Jun 20;32(3):234-235. doi: 10.18176/jiaci.0740. Epub 2021 Jul 26.
6
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.新型冠状病毒疫苗过敏反应风险及推荐评估和管理:系统评价、荟萃分析、GRADE 评估和国际共识方法。
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3546-3567. doi: 10.1016/j.jaip.2021.06.006. Epub 2021 Jun 18.
7
Optimizing investigation of suspected allergy to polyethylene glycols.优化对疑似聚乙二醇过敏的调查。
J Allergy Clin Immunol. 2022 Jan;149(1):168-175.e4. doi: 10.1016/j.jaci.2021.05.020. Epub 2021 May 28.
8
Allergy to COVID-19 vaccines: A current update.新型冠状病毒肺炎疫苗过敏:最新进展
Allergol Int. 2021 Jul;70(3):313-318. doi: 10.1016/j.alit.2021.04.003. Epub 2021 Apr 23.
9
Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine.聚乙二醇(PEG)是辉瑞/ BioNTech mRNA新冠疫苗过敏反应的一个诱因。
Clin Exp Allergy. 2021 Jun;51(6):861-863. doi: 10.1111/cea.13874. Epub 2021 Apr 9.
10
Excipient Hypersensitivity Masquerading as Multidrug Allergy.辅料超敏反应伪装成多药过敏
Am J Med. 2021 Aug;134(8):e447-e448. doi: 10.1016/j.amjmed.2021.02.015. Epub 2021 Mar 31.

药物过敏的新挑战:辅料的再度出现

New Challenges in Drug Allergy: the Resurgence of Excipients.

作者信息

Venturini Díaz Mónica, Vidal Oribe Irene, D'Elia Torrence Diana, Hernández Alfonso Pilar, Alarcón Gallardo Eladia

机构信息

Allergy Department, Hospital Universitario San Pedro, CARPA San Millán, Obispo Lepe Sn., 26004 Logroño, La Rioja Spain.

Allergy Department, Hospital de Calahorra, Calahorra, La Rioja Spain.

出版信息

Curr Treat Options Allergy. 2022;9(3):273-291. doi: 10.1007/s40521-022-00313-6. Epub 2022 Jul 24.

DOI:10.1007/s40521-022-00313-6
PMID:35910462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9308858/
Abstract

PURPOSE OF REVIEW

Allergy to excipients is a cause of multidrug allergy and if it is not taken into account, it can lead to unexpected severe reactions. If an excipient allergy is suspected, an accurate examination followed by algorithms is very important for a correct diagnosis and to give patients detailed information in order to avoid future reactions.

RECENT FINDINGS

In recent times, due to allergy COVID vaccine reactions, interest in excipients as polyethylene glycol derivatives (PEGs) has increased as a possible cause of drug and vaccine hypersensivity. In addition to PEGs many other excipients as gelatin, alpha-gal, protamine, benzalkonium chloride, and benzyl alcohol have been described as a cause of allergy to drugs and vaccines. For most excipients, the dilutions used for skin testing (ST) are not standardized and proper algorithms to reach a diagnosis are not available.

SUMMARY

The purpose of this article is to review the excipients that may produce inmediate hypersensitivity drugs and vaccine reactions and update diagnostic procedures to reach an accurate diagnosis. We highlight the in vivo and in vitro diagnostic tests used in published reports and detail the dilution used for each excipient to perform ST in order to confirm this vital pathology and to prevent new reactions.

摘要

综述目的

辅料过敏是多种药物过敏的一个原因,如果不加以考虑,可能会导致意外的严重反应。如果怀疑存在辅料过敏,进行准确检查并遵循相应流程对于正确诊断以及为患者提供详细信息以避免未来反应非常重要。

最新发现

近来,由于新冠疫苗过敏反应,作为聚乙二醇衍生物(PEGs)的辅料作为药物和疫苗超敏反应的可能原因受到了更多关注。除了PEGs,许多其他辅料如明胶、α-半乳糖、鱼精蛋白、苯扎氯铵和苯甲醇也被描述为药物和疫苗过敏的原因。对于大多数辅料,用于皮肤试验(ST)的稀释液未标准化,且缺乏用于诊断的合适流程。

总结

本文旨在综述可能导致速发型超敏反应的药物和疫苗反应的辅料,并更新诊断程序以实现准确诊断。我们重点介绍了已发表报告中使用的体内和体外诊断测试,并详细说明了用于每种辅料进行皮肤试验的稀释液,以确认这一重要病理情况并预防新的反应。